Compare PulteGroup, Inc. (PHM) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
PulteGroup, Inc. vs Zoetis Inc — how do they compare? PulteGroup, Inc. trades at $112.12 (market cap $21.63B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is the larger of the two by market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold PulteGroup, Inc. for 91 Days and Zoetis Inc for 70 Days on average.
| PHM | ZTS | |
|---|---|---|
Market Cap | $21.63B | $30.20B |
Volume | 2,324,729 | 6,175,327 |
Sector | Consumer Cyclical | Health |
52-Week High | $142.56 | $147.53 |
52-Week Low | $110.11 | $69.09 |
Typical Hold Time | 91 Days | 70 Days |
Enterprise Value | $22.04B | $37.76B |
Dividend Yield | 0.92% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PulteGroup (PHM) trades at $113.53, down 1.07% with bearish technical signals despite reasonable valuations. The stock faces headwinds from rising mortgage rates impacting the housing sector, with recent earnings showing mixed results - missing Q4 2025 and Q1 2026 estimates but beating Q2 2026 expectations. Revenue declined to $17.31B in 2025 with net income margin compression to 11.62%, though the company maintains strong cash flow generation and dividend payments.
While PHM offers attractive valuation metrics including an 11.6 P/E ratio and 45% analyst buy ratings with a $139.80 price target, the stock faces significant near-term pressure from rising interest rates and housing affordability concerns. The bearish technical outlook and mixed earnings performance suggest cautious positioning until clearer housing market stabilization emerges.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About PulteGroup, Inc.
PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.
Read more on PHM →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
